INKT
Mink Therapeutics Inc
NASDAQ: INKT · HEALTHCARE · BIOTECHNOLOGY
$11.81
+8.55% today
Updated 2026-04-29
Market cap
$55.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.93
Dividend yield
—
52W range
$6 – $76
Volume
0.4M
Mink Therapeutics Inc (INKT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |